Intrinsic asthma and bacterial histamine release.

Area of Science:

• Immunology
• Pediatric Respiratory Medicine
• Microbiology

Background:

• Intrinsic asthma (IA) pathogenesis in children remains incompletely understood.
• The role of bacterial infections in exacerbating respiratory diseases is a significant clinical concern.
• Histamine release from immune cells is a key mediator in allergic and inflammatory responses.

Purpose of the Study:

• To investigate the pathogenic role of bacteria in intrinsic asthma (IA) in children.
• To elucidate the mechanisms by which bacteria induce histamine release from leukocytes.
• To differentiate between bacterial histamine release pathways in IA patients and healthy children.

Main Methods:

• Utilized a basophil histamine liberation technique to assess leukocyte responses to bacterial strains.
• Examined histamine release in vitro from peripheral leukocytes of children with IA and healthy controls.
• Analyzed potential mechanisms including IgE-mediated and direct cell surface interactions.

Main Results:

• Several bacterial strains induced histamine release from leukocytes in vitro.
• Children with IA and healthy children showed positive responses, though less frequent in healthy individuals.
• Identified two distinct mechanisms of bacterial histamine release: IgE-dependent and direct cell interaction.

Conclusions:

• Bacteria can trigger histamine release through distinct pathways, involving IgE or direct cell surface interaction.
• A defective pulmonary barrier in IA patients may allow bacterial entry, leading to localized histamine release in the lungs.
• These findings suggest a novel mechanism contributing to the pathogenesis of intrinsic asthma in pediatric populations.